Please assess the completion status of the following clinical trial:

Trial Title: A Phase IV Study of BMS-232632 in HIV+ Patients With Metabolic Syndrome

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~- Documented Metabolic Syndrome by at least 3 of the following parameters:~* Abdominal obesity, assessed by waist circumference (for men \>103 cm, for women \>88 cm).~* Triglycerides \> 150 mg/dl.~* HDL cholestrol (for men \<40 mg/dl, for women \<50 mg/dl).~* Blood pressure \> or equal to 130/85 mm Hg.~* Fasting serum glucose \> or equal to 110 mg/dl.~* HIV RNA \< 50 copies/mL.~* IP within 3 months prior to selection.~Exclusion Criteria:~-Treated Metabolic Syndrom

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).